Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,275 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Non-lethal proteasome inhibition activates pro-tumorigenic pathways in multiple myeloma cells.
Skorda A, Sklirou AD, Sakellaropoulos T, Gianniou DD, Kastritis E, Terpos E, Tsitsilonis OE, Florea BI, Overkleeft HS, Dimopoulos MA, Alexopoulos LG, Trougakos IP. Skorda A, et al. Among authors: dimopoulos ma. J Cell Mol Med. 2019 Dec;23(12):8010-8018. doi: 10.1111/jcmm.14653. Epub 2019 Sep 30. J Cell Mol Med. 2019. PMID: 31568628 Free PMC article.
Current treatments for renal failure due to multiple myeloma.
Kastritis E, Terpos E, Dimopoulos MA. Kastritis E, et al. Among authors: dimopoulos ma. Expert Opin Pharmacother. 2013 Aug;14(11):1477-95. doi: 10.1517/14656566.2013.803068. Epub 2013 May 25. Expert Opin Pharmacother. 2013. PMID: 23705905 Review.
Non-secretory myeloma: one, two, or more entities?
Dimopoulos MA, Kastritis E, Terpos E. Dimopoulos MA, et al. Oncology (Williston Park). 2013 Sep;27(9):930-2. Oncology (Williston Park). 2013. PMID: 24282994 Free article. No abstract available.
Efficacy and safety of elotuzumab for the treatment of multiple myeloma.
Gavriatopoulou M, Terpos E, Kastritis E, Dimopoulos MA. Gavriatopoulou M, et al. Among authors: dimopoulos ma. Expert Opin Drug Saf. 2017 Feb;16(2):237-245. doi: 10.1080/14740338.2017.1279603. Epub 2017 Jan 11. Expert Opin Drug Saf. 2017. PMID: 28060563 Review.
Proteasome Inhibitors in Waldenström Macroglobulinemia.
Kastritis E, Dimopoulos MA. Kastritis E, et al. Among authors: dimopoulos ma. Hematol Oncol Clin North Am. 2018 Oct;32(5):829-840. doi: 10.1016/j.hoc.2018.05.011. Epub 2018 Jul 25. Hematol Oncol Clin North Am. 2018. PMID: 30190021 Review.
Toll-Like Receptor 4 Activation Promotes Multiple Myeloma Cell Growth and Survival Via Suppression of The Endoplasmic Reticulum Stress Factor Chop.
Bagratuni T, Sklirou AD, Kastritis E, Liacos CI, Spilioti C, Eleutherakis-Papaiakovou E, Kanellias N, Gavriatopoulou M, Terpos E, Trougakos IP, Dimopoulos MA. Bagratuni T, et al. Among authors: dimopoulos ma. Sci Rep. 2019 Mar 1;9(1):3245. doi: 10.1038/s41598-019-39672-7. Sci Rep. 2019. PMID: 30824741 Free PMC article.
How I treat relapsed multiple myeloma.
Kastritis E, Terpos E, Dimopoulos MA. Kastritis E, et al. Among authors: dimopoulos ma. Blood. 2022 May 12;139(19):2904-2917. doi: 10.1182/blood.2020008734. Blood. 2022. PMID: 35007326 Free article.
1,275 results